Litigation Update: Zantac MDL Procedures Are Announced

On April 1, 2020, the FDA requested the recall of all ranitidine heartburn medication products (commonly known by the brand name Zantac) because of the risks posed by NDMA contamination in some samples tested. Last week, Judge Robin L. Rosenberg, who is presiding over the MDL involving this drug currently venued in the U.S. District … Continue reading “Litigation Update: Zantac MDL Procedures Are Announced”

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved